Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada · Delayed Price · Currency is CAD 1.800
-0.100 (-5.26%)
Nov 6, 2026, 12:48 PM EST
TSXV:EBM Market Cap
TSXV:EBM has a market cap or net worth of CAD 123.99 million as of November 6, 2026. It is the 25,731st most valuable company in the world and the 683rd biggest in Canada. Its market cap has increased by 116.87% in one year.
Market Cap
123.99M
Enterprise Value
124.05M
Revenue
812.12K
Global Rank
Country Rank
#683 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since September 19, 2014, TSXV:EBM's market cap has increased from 26.94M to 123.99M, an increase of 360.22%. That is a compound annual growth rate of 13.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 123.99M | 122.22% |
| Dec 31, 2025 | 55.80M | 50.00% |
| Dec 31, 2024 | 37.20M | -1.82% |
| Dec 6, 2023 | 37.89M | -45.00% |
| Dec 30, 2022 | 68.89M | -28.57% |
| Dec 30, 2021 | 96.44M | -30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 256.47M |
| Satellos Bioscience | 214.71M |
| Helix BioPharma | 68.74M |
| BriaCell Therapeutics | 48.64M |
| NurExone Biologic | 48.20M |
| Thiogenesis Therapeutics | 44.79M |
| Sharp Therapeutics | 43.26M |
| Sernova Biotherapeutics | 41.54M |